Prostatis Group’s Adams Diversified Equity Fund ADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$745K Buy
34,036
+674
+2% +$15.5K 0.19% 87
2025
Q4
$778K Sell
33,362
-204
-0.6% -$4.67K 0.19% 83
2025
Q3
$749K Buy
33,566
+688
+2% +$15K 0.19% 85
2025
Q2
$714K Sell
32,878
-1,180
-3% -$23.3K 0.2% 88
2025
Q1
$647K Sell
34,058
-207
-0.6% -$4.16K 0.2% 84
2024
Q4
$692K Buy
34,265
+2,960
+9% +$63.2K 0.2% 87
2024
Q3
$675K Buy
31,305
+634
+2% +$13.5K 0.22% 77
2024
Q2
$659K Buy
30,671
+75
+0.2% +$1.5K 0.23% 84
2024
Q1
$597K Buy
30,596
+32
+0.1% +$595 0.23% 87
2023
Q4
$541K Buy
30,564
+1,935
+7% +$32.9K 0.23% 80
2023
Q3
$476K Buy
28,629
+80
+0.3% +$1.38K 0.23% 67
2023
Q2
$480K Buy
28,549
+89
+0.3% +$1.42K 0.22% 74
2023
Q1
$444K Buy
28,460
+56
+0.2% +$853 0.23% 70
2022
Q4
$413K Buy
28,404
+1,640
+6% +$24.8K 0.25% 70
2022
Q3
$390K Buy
26,764
+82
+0.3% +$1.32K 0.45% 40
2022
Q2
$409K Buy
26,682
+81
+0.3% +$1.34K 0.64% 18
2022
Q1
$491K Buy
26,601
+74
+0.3% +$1.35K 0.39% 41
2021
Q4
$515K Buy
26,527
+3,417
+15% +$68.7K 0.32% 49
2021
Q3
$458K Buy
23,110
+56
+0.2% +$1.14K 0.27% 61
2021
Q2
$456K Buy
23,054
+59
+0.3% +$1.13K 0.31% 60
2021
Q1
$420K Buy
22,995
+51
+0.2% +$906 0.33% 67
2020
Q4
$397K Buy
22,944
+1,123
+5% +$18.9K 0.33% 57
2020
Q3
$354K Buy
21,821
+63
+0.3% +$1.01K 0.34% 57
2020
Q2
$324K Buy
21,758
+73
+0.3% +$1.04K 0.65% 44
2020
Q1
$273K Buy
21,685
+74
+0.3% +$1.1K 0.39% 35
2019
Q4
$341K Buy
+21,611
New +$344K 0.31% 59

Other funds holding ADX

Prostatis Group's ADX Position: Q1 2026 in Review

Prostatis Group increased its Adams Diversified Equity Fund (ADX) stake by 2% in Q1 2026, buying an estimated $15.5K and bringing the position to 34,036 shares worth $745K. The position accounts for 0.19% of the portfolio, ranked #87.

Prostatis Group first reported a position in ADX in Q4 2019 and has held it in 26 quarters since. The position peaked at $778K in Q4 2025. 199 funds tracked by Wall St. Rank hold ADX as of Q1 2026.

  • Prostatis Group held 34,036 shares of Adams Diversified Equity Fund worth $745K as of Q1 2026.
  • Prostatis Group bought 674 Adams Diversified Equity Fund shares in Q1 2026, an estimated $15.5K.
  • Adams Diversified Equity Fund made up 0.19% of Prostatis Group's portfolio in Q1 2026, its #87 holding.
  • Prostatis Group first reported a position in Adams Diversified Equity Fund in Q4 2019 and has held it in 26 quarters since.
  • Prostatis Group's Adams Diversified Equity Fund position peaked at $778K in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Adams Diversified Equity Fund as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.